TL;DR — Creatine and Bipolar Disorder
Bipolar disorder is a complex psychiatric condition characterized by alternating episodes of depression and mania. An emerging understanding of the disorder highlights the role of brain energy metabolism — specifically, mitochondrial dysfunction and altered ATP production — in driving mood episodes. The brain energy hypothesis of bipolar disorder proposes that depressive episodes are associated with reduced cerebral energy availability, while manic episodes may involve dysregulated energy metabolism. Creatine, through its role in the phosphocreatine energy buffer system, has been investigated as a potential adjunctive treatment for bipolar depression. The Toniolo et al. (2017) trial provided early clinical evidence that creatine supplementation may improve depressive symptoms in bipolar disorder when added to standard treatment. While these results are promising, they remain preliminary and require replication.
The Brain Energy Hypothesis
The brain energy hypothesis of bipolar disorder is supported by multiple lines of evidence:
Mitochondrial dysfunction. Studies consistently find mitochondrial abnormalities in bipolar patients, including reduced electron transport chain activity, altered mitochondrial morphology, and decreased ATP production capacity.
Neuroimaging evidence. Magnetic resonance spectroscopy (MRS) studies have identified altered levels of phosphocreatine, ATP, and other energy-related metabolites in the brains of bipolar patients, particularly during depressive episodes.
Genetic links. Several genes associated with bipolar risk are involved in mitochondrial function and energy metabolism, supporting an intrinsic connection between energy dysregulation and mood instability.
Medication mechanisms. Interestingly, some effective bipolar medications (including lithium and valproate) have been shown to influence mitochondrial function and energy metabolism, suggesting that therapeutic effects may partly operate through energy pathways.
The phosphocreatine system, as the brain’s primary rapid energy buffer, is positioned at the intersection of these energy-related mechanisms (T et al., 2011) .
Toniolo et al. (2017): Clinical Evidence
The randomized, double-blind, placebo-controlled trial by Toniolo and colleagues in 2017 represents the most direct clinical evidence for creatine in bipolar disorder. This study specifically examined creatine as an add-on treatment for bipolar depression — the depressive phase of bipolar disorder, which is often more treatment-resistant than the manic phase.
Key aspects of this study:
Study design. Bipolar II patients experiencing a depressive episode received either creatine (6g/day) or placebo in addition to their standard medications for 6 weeks.
Depression improvement. The creatine group showed statistically significant improvement in depressive symptoms compared to placebo, as measured by standardized depression rating scales.
Mania safety. Importantly, creatine supplementation did not trigger manic episodes — a critical safety consideration in bipolar disorder treatment. The rate of treatment-emergent mania was not higher in the creatine group.
Brain changes. MRS measurements showed changes in brain phosphocreatine levels in the creatine group, providing a biological correlate for the observed clinical improvement.
Creatine and Depression: Broader Context
The interest in creatine for bipolar depression fits within a broader research context examining creatine’s mood-modulating effects. Kious et al. (2019) reviewed the evidence for creatine in depressive conditions more broadly (BM et al., 2019) :
Unipolar depression. Several studies have investigated creatine as an adjunctive treatment for major depressive disorder, with generally positive results, particularly in women.
Brain energy and mood. The relationship between brain energy availability and mood regulation is well-established. Depression is associated with reduced cerebral energy metabolism, and treatments that improve energy availability may support mood recovery.
Gender differences. Some research suggests women may respond more robustly to creatine supplementation for mood, possibly due to lower baseline creatine levels compared to men.
Roschel et al. (2021) noted the emerging evidence for creatine in psychiatric conditions, calling for larger, well-designed clinical trials (H et al., 2021) .
Important Safety Considerations
Creatine supplementation in bipolar disorder requires careful consideration:
Not a standalone treatment. Creatine is NOT an approved treatment for bipolar disorder and should NEVER replace prescribed medications. Bipolar disorder requires comprehensive psychiatric management.
Mania risk. While the Toniolo et al. (2017) trial did not find increased mania rates, the theoretical possibility that enhancing brain energy could contribute to manic states has not been fully ruled out. Medical supervision is essential.
Drug interactions. While creatine has no known significant interactions with common bipolar medications, the complexity of bipolar pharmacotherapy warrants discussion with a prescribing psychiatrist.
Individual variation. Bipolar disorder is highly heterogeneous, and individual responses to any intervention, including creatine, may vary significantly.
The ISSN confirms creatine’s general safety profile (RB et al., 2017) , but specific safety in the bipolar population requires further study.
Malaysian Context: Mental Health
Bipolar disorder and mental health have important Malaysian dimensions:
Prevalence. Bipolar disorder affects Malaysians across all demographics. The National Health and Morbidity Survey has identified significant mental health challenges in the Malaysian population, though bipolar disorder specifically remains underdiagnosed.
Stigma. Mental health stigma in Malaysia can delay diagnosis and treatment of bipolar disorder. Public education about mood disorders remains an important health priority.
Treatment access. Psychiatric services are available at major government and private hospitals, but specialist psychiatric care can be difficult to access in rural areas.
Cultural context. Some Malaysian communities may interpret bipolar symptoms through cultural or spiritual frameworks rather than as a medical condition, potentially delaying evidence-based treatment.
Support resources. Malaysians experiencing mental health challenges can contact the MHPSS line (03-2935 9935) or Befrienders KL (03-7956 8145). Creatine supplementation should only be considered as a complement to professional psychiatric care, never as a replacement.
Creatine monohydrate is available in Malaysia from RM40 per month. Anyone with bipolar disorder should consult their psychiatrist before starting any supplement.
Sources & References
This article cites Kious et al. (2019) on creatine and mood, Roschel et al. (2021) on brain health, and Kreider et al. (2017) ISSN position stand. Full citations with DOI links are available in our Research Library.